Every 424B that Inuvo, Inc. (INUV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INUV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INUV filings page.
Inuvo, Inc. has filed a prospectus covering the resale by existing holders of up to 6,086,069 shares of common stock issuable upon exercise of outstanding warrants. These include 2,968,814 shares from Class A Warrants, 2,968,814 from Class B Warrants, and 148,441 from Placement Agent Warrants issued in a prior July 1, 2026 financing.
The company is not selling shares in this offering and will not receive proceeds from resales, but could receive approximately $7.8 million if all common warrants are exercised for cash. Common stock outstanding was 16,483,079 shares as of July 23, 2026 and would be 22,569,148 shares assuming full warrant exercise.
In June 2026, Inuvo completed a $10 million non-dilutive financing via two secured promissory notes, using proceeds to repay approximately $2.8 million of convertible debt and terminate a receivables-based credit facility, leaving no outstanding convertible debt. The company highlights AI-driven advertising technology, particularly its IntentKey large language model platform, and notes industry shifts around privacy, cookies, and traffic quality.
Inuvo, Inc. is offering 1,631,121 shares of common stock at $1.00 per share and, in lieu of some shares, pre-funded warrants to purchase up to 1,337,693 shares at $0.999 per warrant. The company also completed a concurrent private placement of warrants to purchase up to 5,937,628 shares, divided into Class A and Class B Warrants.
The offering is being conducted with Ladenburg Thalmann as placement agent on a best-efforts basis. Net proceeds to the company before expenses are approximately $2.6 million, and the company states proceeds will be used for working capital. The placement agent will receive fees and placement agent warrants; certain insiders are subject to lock-ups.
INUV suspends its at-the-market (ATM) offering and terminates continuous sales effective June 30, 2026. The prospectus supplement states the company may offer and sell common stock having an aggregate offering price of up to $15,000,000 under the Offering Agreement with H.C. Wainwright.
The supplement reports the company has sold 165,641 shares through the sales agent, generating $1,184,740 in gross proceeds to date. The supplement also states the last reported sale price was $1.36 per share on June 29, 2026. The Offering Agreement remains in full force and effect, but no sales will occur under it unless a new prospectus supplement is filed.
Inuvo, Inc. is registering up to 5,000,000 shares of common stock for resale by a single selling stockholder, 3i, LP. These shares are issuable upon conversion of a $3,333,333 Convertible Note with a conversion price of $3.10 per share, subject to adjustments with a minimum of $0.736.
The company already sold the Convertible Note in a private placement and received gross proceeds of $3 million, which it plans to use for general corporate purposes, including working capital. Inuvo will not receive any proceeds from the resale of the shares covered by this prospectus.
Inuvo operates an advertising technology business built around proprietary generative large language AI that targets audiences without using consumer identity or data. Key risks highlighted include potential dilution from share issuances, stock price volatility, reliance on major customers and partners, cybersecurity threats, regulatory and privacy compliance, possible future financings that may be dilutive, and the lack of anticipated cash dividends in the foreseeable future.